2nd Quarter - Amendment

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,520,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 19, 2012 $1,420,000 Replaced
2nd Quarter - Amendment (this page) Jun 14, 2013 $1,520,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Discussions related to international intellectual propterty issues.

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commcercially benefit sanofi-aventis U.S . Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

General issues related to prescription drug supply chain, including importation safety, foreign inspections, track and trace, and drug shortage, including related amendments to HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5651 (112th)

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"; and efforts to add Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commcercially benefit sanofi-aventis U.S . Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 942 (112th)

Economics/Economic Development ECN

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

Foreign entity interest: Sanofi SA, the foreign parent corporation of sanofi-aventis U.S. Inc., as disclosed on its LD-1

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5910 (112th)

Health Issues HCR

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commcercially benefit sanofi-aventis U.S . Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
AMY L REDL —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4223 (112th), H.R. 3627 (112th), H.R. 436 (112th), H.R. 2405 (112th), H.R. 2529 (112th)

Animals ANI

HR3798 "Egg Products Inspection Act Amendments of 2012" - all provisions; issues related to a National Environmental Policy Act (NEPA) exclusion for veterinary biologics; and general issues related to the USDA Wildlife Service Oral Rabies Vaccination Program.

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commcercially benefit sanofi-aventis U.S . Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
PATRICK MAYES MCLAIN —
AMY L REDL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3798 (112th)

Medical/Disease Research/Clinical Labs MED

Reauthorization of the Prescription Drug User Fee Act (PDUFA) including potential amendments and all provisions of HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
AMY L REDL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5651 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.